Rafferty Asset Management, LLC

Position in FDMT — 4D Molecular Therapeutics, Inc.

CIK 1389426 New York, NY

Position in FDMT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$594,696

-$70,000 QoQ

Shares Held

44,714

-37.4% QoQ

Ownership

0.062%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#72

of 158 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. FDMT ranks #111 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	65,798	$32,683,840
2	REGN	Regeneron Pharmaceuticals, Inc.	38,534	$24,027,490
3	ALNY	Alnylam Pharmaceuticals, Inc.	55,332	$16,656,591
4	MRNA	Moderna, Inc.	111,906	$7,836,777
5	INCY	Incyte Corp	44,663	$5,062,997
6	APGE	Apogee Therapeutics, Inc.	33,369	$4,429,067
7	ORKA	Oruka Therapeutics, Inc.	43,110	$4,102,778
8	KYMR	Kymera Therapeutics, Inc.	35,287	$4,046,360

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$594,696	44,714	-37.4%	Shares	Sole	2026-08-14
2026-03-31	$664,696	71,396	-14.4%	Shares	Sole	2026-05-15
2025-12-31	$625,597	83,413	-7.7%	Shares	Sole	2026-02-13
2024-09-30	$976,661	90,348	-5.5%	Shares	Sole	2024-11-13
2024-06-30	$2,005,909	95,565	-50.3%	Shares	Sole	2024-08-13
2024-03-31	$6,129,258	192,381	+52.0%	Shares	Sole	2024-05-13
2023-12-31	$2,564,693	126,589	-21.5%	Shares	Sole	2024-02-13
2023-09-30	$2,053,170	161,286	-18.2%	Shares	Sole	2023-11-13
2023-06-30	$3,562,590	197,155	+46.3%	Shares	Sole	2023-08-11
2023-03-31	$2,317,005	134,788	+181.2%	Shares	Sole	2023-05-11
2022-12-31	$1,064,591	47,933	-33.2%	Shares	Sole	2023-02-13
2022-03-31	$1,085,222	71,774	-5.2%	Shares	Sole	2022-05-13
2021-12-31	$1,661,143	75,713	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.